Trademarkia Logo

Australia

AU$
ANJI
Cancelled: Cancelled at the request of IB

Last updated on 13 Feb 2025

Owner Info

Anji Pharmaceuticals Inc.

245 Main Street

Cambridge MA 02143, UNITED STATES OF AMERICA

Serial Number

2251701 filed on 30 Nov 2021

Correspondent

Jenevieve Maerker, Esq. Foley Hoag LLP

155 Seaport Boulevard,

Boston MA 02210,

UNITED STATES OF AMERICA

ANJI

Classification Information


Class [005]
Pharmaceutical preparations for human use; pharmaceutical preparations for human use.

Mark Details


Serial Number

2251701

Registered On

30 Nov 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

22 Jul 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
13th Feb 2025Status change to Voided
10th May 2022International Registration in Australia Protected correspondence sent
9th May 2022IP Right Registration Published
9th May 2022Status change to Registered/Protected
3rd Mar 2022Application Accepted correspondence sent
2th Mar 2022IP Right has been Examined
2th Mar 2022IP Right Acceptance Published
2th Mar 2022Status change to Accepted
1st Mar 2022Examination expedited
1st Mar 2022Awaiting examination